omeprazole has been researched along with Abdominal Pain in 45 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Poliprotect proved noninferior to standard-dose omeprazole in symptomatic patients with heartburn/epigastric burning without erosive esophagitis and gastroduodenal lesions." | 9.69 | Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial. ( Annibale, B; Badiali, D; Bassotti, G; Bragazzi, MC; Ciacci, C; Cicala, M; Corazziari, ES; D'Alba, L; D'Ovidio, V; Di Sabatino, A; Gasbarrini, A; Iovino, P; Marazzato, M; Neri, M; Passaretti, S; Radocchia, G; Repici, A; Ribichini, E; Riggio, O; Schippa, S, 2023) |
| "05) lower percentages of days and nights with heartburn, less pain severity of both day and night heartburn, fewer days of antacid use, and smaller amounts of antacid use compared with patients who were treated with ranitidine or placebo." | 9.09 | Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease. ( Campbell, DR; Fludas, C; Huang, B; Kahrilas, PJ; Richter, JE, 2000) |
| "Lansoprazole is an effective and safe treatment for duodenal ulcer and the 15 mg dose is as effective as 30 or 60 mg." | 9.08 | A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group. ( Avner, DL; Dorsch, ER; Greski-Rose, PA; Jennings, DE, 1995) |
| " Total relief of heartburn, the most common symptom at entry, was achieved by more patients in the omeprazole treatment group than the antacid-alginate/ranitidine treatment group, 62 vs." | 9.08 | The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. ( Evans, WM; Mason, I; Millar, LJ; Sheikh, RR; Taylor, MD; Todd, PL; Turbitt, ML, 1998) |
| "The efficacy and safety of omeprazole, in 241 patients with active recurrent duodenal ulcer from 21 Italian centres, was studied in a multicentre double-blind randomized trial comparing 20 mg omeprazole o." | 9.07 | Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease. ( Annibale, B; Cassetta, MR; Delle Fave, G; Franceschi, M; Quatrini, M; Torsoli, A, 1992) |
| "Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 7.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
| "Poliprotect proved noninferior to standard-dose omeprazole in symptomatic patients with heartburn/epigastric burning without erosive esophagitis and gastroduodenal lesions." | 5.69 | Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial. ( Annibale, B; Badiali, D; Bassotti, G; Bragazzi, MC; Ciacci, C; Cicala, M; Corazziari, ES; D'Alba, L; D'Ovidio, V; Di Sabatino, A; Gasbarrini, A; Iovino, P; Marazzato, M; Neri, M; Passaretti, S; Radocchia, G; Repici, A; Ribichini, E; Riggio, O; Schippa, S, 2023) |
| "Lymphocytic gastritis is characterized by intense lymphocytic infiltration of gastric epithelium." | 5.31 | [Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole]. ( Bellanger, J; Cacoub, P; Costedoat-Chalumeau, N; Godeau, P; Piette, JC; Sbaï, A, 2000) |
| "05) lower percentages of days and nights with heartburn, less pain severity of both day and night heartburn, fewer days of antacid use, and smaller amounts of antacid use compared with patients who were treated with ranitidine or placebo." | 5.09 | Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease. ( Campbell, DR; Fludas, C; Huang, B; Kahrilas, PJ; Richter, JE, 2000) |
| "Lansoprazole is an effective and safe treatment for duodenal ulcer and the 15 mg dose is as effective as 30 or 60 mg." | 5.08 | A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group. ( Avner, DL; Dorsch, ER; Greski-Rose, PA; Jennings, DE, 1995) |
| "Patients with active HP infection and peptic ulcer, a history of peptic ulcer, or nonulcer dyspepsia were randomized to either lansoprazole 30 mg b." | 5.08 | Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. ( Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM, 1997) |
| " Total relief of heartburn, the most common symptom at entry, was achieved by more patients in the omeprazole treatment group than the antacid-alginate/ranitidine treatment group, 62 vs." | 5.08 | The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. ( Evans, WM; Mason, I; Millar, LJ; Sheikh, RR; Taylor, MD; Todd, PL; Turbitt, ML, 1998) |
| "Although bismuth was both the first drug shown to alter the natural history of peptic ulcer disease and also a constituent of the first very effective eradication regimens, it has been excluded from the newer regimens, despite its safety and low cost, in favour of two antibiotics." | 5.08 | Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication. ( Scott, BB, 1998) |
| "The efficacy and safety of omeprazole, in 241 patients with active recurrent duodenal ulcer from 21 Italian centres, was studied in a multicentre double-blind randomized trial comparing 20 mg omeprazole o." | 5.07 | Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease. ( Annibale, B; Cassetta, MR; Delle Fave, G; Franceschi, M; Quatrini, M; Torsoli, A, 1992) |
| "Patients who had heartburn twice a week or more were treated with 20 mg omeprazole (OPZ) once daily for 8 wk as an initial therapy (study 1)." | 3.77 | Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan. ( Fujiwara, A; Ishioka, H; Kawahara, Y; Nasu, J; Okada, H; Takenaka, R; Tsuzuki, T; Yamamoto, K; Yoshinaga, F, 2011) |
| " Eight days before admission she had started and continued to take pantoprazole because of symptoms of gastroesophageal reflux." | 3.72 | [Pantoprazole-induced hepatitis]. ( Cordes, A; Maier, KP; Vogt, W, 2003) |
| "Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 3.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
| "These findings indicate that (1) peptic esophagitis was a common cause of chronic abdominal pain in pediatric patients and (2) omeprazole was effective in the treatment of esophagitis in children and adolescents that was resistant to high-dose histamine2-receptor antagonists." | 3.69 | Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy. ( Kane, R; Karjoo, M, 1995) |
| "To review the literature on the treatment of gastroesophageal reflux disease (GERD) with emphasis on pharmacological aspects." | 2.43 | Treatment of gastroesophageal reflux disease. ( Camargos, PA; Guimarães, EV; Marguet, C, 2006) |
| "Among those cases, isolated gastric Crohn's disease is even rarer." | 1.51 | Pyloric stenosis as a manifestation of isolated gastric Crohn's disease responding to intralesional steroid injection and balloon dilation: a case report. ( Balendran, K; Nawaraththne, NMM; Udumalagala, S, 2019) |
| "Acute massive gastric dilatation (AMGD) is a recognised complication after Nissen fundoplication." | 1.48 | Massive gastric dilatation leading to acute respiratory distress 1 year after a Nissen fundoplication. ( Alasadi, A; DiMaggio, F; Mukherjee, D; Sohrabi, F, 2018) |
| "The gastrinoma was present in a lymph node close to the greater curvature of the stomach." | 1.37 | Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome. ( Nazir, Z, 2011) |
| "Acute pancreatitis is a pancreatic inflammation that recognises Salmonella typhi among its aetiological agents." | 1.34 | [Typhoid fever and acute pancreatitis: two cases]. ( Bertuccio, SN; Rombolà, F, 2007) |
| "In conclusion, GERD in children manifests differently than that in adults and symptoms vary with patient age." | 1.33 | Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. ( Amer, F; Chiu, YL; Gupta, SK; Hassall, E; Heyman, MB, 2006) |
| "To estimate the rates of common adverse events in patients treated with the proton pump inhibitors omeprazole, lansoprazole and pantoprazole in general practice in England." | 1.31 | The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. ( Dunn, NR; Freemantle, S; Martin, RM; Shakir, S, 2000) |
| "Treatment with omeprazole, amoxicillin, and clarithromycin resulted in eradication of the infection in all and in resolution of the clinical symptoms in 15 (80%) of 19 patients who had a follow-up examination." | 1.31 | Helicobacter pylori infection in recurrent abdominal pain. ( Braegger, CP; Frank, F; Stallmach, T; Stricker, T, 2000) |
| "Lymphocytic gastritis is characterized by intense lymphocytic infiltration of gastric epithelium." | 1.31 | [Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole]. ( Bellanger, J; Cacoub, P; Costedoat-Chalumeau, N; Godeau, P; Piette, JC; Sbaï, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (24.44) | 18.2507 |
| 2000's | 23 (51.11) | 29.6817 |
| 2010's | 8 (17.78) | 24.3611 |
| 2020's | 3 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Del Pozo-García, AJ | 1 |
| Valdeés-Lacasa, T | 1 |
| Fresneda-Cuesta, D | 1 |
| Sánchez-Gómez, F | 1 |
| Tamames Gómez, S | 1 |
| Corazziari, ES | 1 |
| Gasbarrini, A | 1 |
| D'Alba, L | 1 |
| D'Ovidio, V | 1 |
| Riggio, O | 1 |
| Passaretti, S | 1 |
| Annibale, B | 2 |
| Cicala, M | 1 |
| Repici, A | 1 |
| Bassotti, G | 1 |
| Ciacci, C | 1 |
| Di Sabatino, A | 1 |
| Neri, M | 1 |
| Bragazzi, MC | 1 |
| Ribichini, E | 1 |
| Radocchia, G | 1 |
| Iovino, P | 1 |
| Marazzato, M | 1 |
| Schippa, S | 1 |
| Badiali, D | 1 |
| Balendran, K | 1 |
| Udumalagala, S | 1 |
| Nawaraththne, NMM | 1 |
| Santos Santamarta, F | 1 |
| Bonoso Criado, R | 1 |
| Pérez-Millán, AG | 1 |
| Takata, K | 1 |
| Fukuda, H | 1 |
| Umeda, K | 1 |
| Yamauchi, R | 1 |
| Fukuda, S | 1 |
| Kunimoto, H | 1 |
| Tanaka, T | 1 |
| Yokoyama, K | 1 |
| Morihara, D | 1 |
| Takeyama, Y | 1 |
| Irie, M | 1 |
| Shakado, S | 1 |
| Sakisaka, S | 1 |
| Sohrabi, F | 1 |
| DiMaggio, F | 1 |
| Alasadi, A | 1 |
| Mukherjee, D | 1 |
| Baños Madrid, R | 1 |
| Alemán Lorca, F | 1 |
| Alajarín Cervera, M | 1 |
| Serrano Jiménez, A | 1 |
| Alberca de las Parras, F | 1 |
| Molina Martínez, J | 1 |
| Carballo Alvarez, F | 1 |
| Tsuzuki, T | 1 |
| Okada, H | 1 |
| Kawahara, Y | 1 |
| Takenaka, R | 1 |
| Nasu, J | 1 |
| Ishioka, H | 1 |
| Fujiwara, A | 1 |
| Yoshinaga, F | 1 |
| Yamamoto, K | 1 |
| Nazir, Z | 1 |
| Veres, G | 1 |
| Korponay-Szabó, I | 1 |
| Maka, E | 1 |
| Glasz, T | 1 |
| Mamula, P | 1 |
| Schuster, V | 2 |
| Tefs, K | 2 |
| Papp, M | 1 |
| Dezsöfi, A | 1 |
| Arató, A | 1 |
| Kloesel, B | 1 |
| Chandan, VS | 1 |
| Alexander, GL | 1 |
| Gerada, J | 1 |
| Borg, E | 1 |
| DeGaetano, J | 1 |
| Pocock, J | 1 |
| Malnick, SD | 1 |
| Gottesfeld, F | 1 |
| Walpart, A | 1 |
| Keter, D | 1 |
| Lurie, Y | 1 |
| Beergabel, M | 1 |
| Cordes, A | 1 |
| Vogt, W | 1 |
| Maier, KP | 1 |
| Wellhöfer, B | 1 |
| Vakil, N | 1 |
| Di Mario, F | 1 |
| Ingegnoli, A | 1 |
| Dal Bò, N | 1 |
| Cavestro, GM | 1 |
| Moussa, AM | 1 |
| Cavallaro, LG | 1 |
| Aragona, G | 1 |
| Iori, V | 1 |
| Pilotto, A | 1 |
| Franzè, A | 1 |
| Rugge, M | 1 |
| Tiesmeier, J | 1 |
| Hinner, H | 1 |
| Kraus, J | 1 |
| Schuppert, F | 1 |
| Ashorn, M | 1 |
| Rägö, T | 1 |
| Kokkonen, J | 1 |
| Ruuska, T | 1 |
| Rautelin, H | 1 |
| Karikoski, R | 1 |
| Agar, M | 1 |
| Webster, R | 1 |
| Lacey, J | 1 |
| Donovan, B | 1 |
| Walker, A | 1 |
| Colls, BM | 1 |
| Menzies, OH | 1 |
| Biswal, N | 1 |
| Ananathakrishnan, N | 1 |
| Kate, V | 1 |
| Srinivasan, S | 1 |
| Nalini, P | 1 |
| Mathai, B | 1 |
| Suzuki, H | 1 |
| Masaoka, T | 1 |
| Sakai, G | 1 |
| Ishii, H | 1 |
| Hibi, T | 1 |
| Gupta, SK | 1 |
| Hassall, E | 1 |
| Chiu, YL | 1 |
| Amer, F | 1 |
| Heyman, MB | 1 |
| Guimarães, EV | 1 |
| Marguet, C | 1 |
| Camargos, PA | 1 |
| Higuchi, K | 1 |
| Rombolà, F | 1 |
| Bertuccio, SN | 1 |
| Kori, M | 1 |
| Cohen, S | 1 |
| Levine, A | 1 |
| Givony, S | 1 |
| Sokolovskaia-Ziv, N | 1 |
| Melzer, E | 1 |
| Granot, E | 1 |
| Sood, A | 1 |
| Sharma, M | 1 |
| Jain, NP | 1 |
| Chawla, LS | 1 |
| Kumar, R | 1 |
| Karjoo, M | 1 |
| Kane, R | 1 |
| Avner, DL | 1 |
| Dorsch, ER | 1 |
| Jennings, DE | 1 |
| Greski-Rose, PA | 1 |
| Weber, L | 1 |
| Chey, WD | 1 |
| Fisher, L | 1 |
| Elta, GH | 1 |
| Barnett, JL | 1 |
| Nostrant, T | 1 |
| DelValle, J | 1 |
| Hasler, WL | 1 |
| Scheiman, JM | 1 |
| Carnicer, J | 1 |
| Mason, I | 1 |
| Millar, LJ | 1 |
| Sheikh, RR | 1 |
| Evans, WM | 1 |
| Todd, PL | 1 |
| Turbitt, ML | 1 |
| Taylor, MD | 1 |
| Scott, BB | 1 |
| Wiklund, I | 1 |
| Glise, H | 1 |
| Jerndal, P | 1 |
| Carlsson, J | 1 |
| Talley, NJ | 1 |
| Dammann, HG | 1 |
| Fölsch, UR | 1 |
| Hahn, EG | 1 |
| von Kleist, DH | 1 |
| Klör, HU | 1 |
| Kirchner, T | 1 |
| Strobel, S | 1 |
| Kist, M | 1 |
| Shamaly, H | 1 |
| Berkowitz, D | 1 |
| Rosenthal, E | 1 |
| Naveh, Y | 1 |
| Richter, JE | 1 |
| Campbell, DR | 1 |
| Kahrilas, PJ | 1 |
| Huang, B | 1 |
| Fludas, C | 1 |
| Martin, RM | 1 |
| Dunn, NR | 1 |
| Freemantle, S | 1 |
| Shakir, S | 1 |
| Frank, F | 1 |
| Stricker, T | 1 |
| Stallmach, T | 1 |
| Braegger, CP | 1 |
| Cacoub, P | 1 |
| Sbaï, A | 1 |
| Costedoat-Chalumeau, N | 1 |
| Bellanger, J | 1 |
| Godeau, P | 1 |
| Piette, JC | 1 |
| Delle Fave, G | 1 |
| Franceschi, M | 1 |
| Quatrini, M | 1 |
| Cassetta, MR | 1 |
| Torsoli, A | 1 |
3 reviews available for omeprazole and Abdominal Pain
| Article | Year |
|---|---|
Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatis.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydia trachomati | 2018 |
Epigastric pain in dyspepsia and reflux disease.
Topics: Abdominal Pain; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Gastroesophageal Reflux; He | 2003 |
Treatment of gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Anti-Ulcer Agents; Barre | 2006 |
11 trials available for omeprazole and Abdominal Pain
| Article | Year |
|---|---|
Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial.
Topics: Abdominal Pain; Anti-Ulcer Agents; Double-Blind Method; Dyspepsia; Esophagitis; Heartburn; Humans; O | 2023 |
Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial.
Topics: Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Double | 2004 |
A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Ulcer Agents; Double-Blin | 1995 |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; B | 1997 |
The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
Topics: Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Alginates; Anti-Ulcer Agents; Biocompati | 1998 |
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; | 1998 |
Does endoscopy have a positive impact on quality of life in dyspepsia?
Topics: Abdominal Pain; Activities of Daily Living; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer A | 1998 |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ul | 2000 |
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool | 2000 |
Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Aged, 80 and over; Antacids; A | 2000 |
Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Metho | 1992 |
31 other studies available for omeprazole and Abdominal Pain
| Article | Year |
|---|---|
Perforation of a decubitus gastric ulcer during intragastric balloon retrieval after surreptitious withdrawal of omeprazole.
Topics: Abdominal Pain; Gastric Balloon; Humans; Male; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer; Yo | 2022 |
Pyloric stenosis as a manifestation of isolated gastric Crohn's disease responding to intralesional steroid injection and balloon dilation: a case report.
Topics: Abdominal Pain; Adult; Azathioprine; Crohn Disease; Dilatation; Endoscopy, Digestive System; Female; | 2019 |
Luetic gastritis: an uncommon cause of gastritis.
Topics: Abdominal Pain; Adult; Gastritis; Humans; Nausea; Omeprazole; Vomiting | 2020 |
Massive gastric dilatation leading to acute respiratory distress 1 year after a Nissen fundoplication.
Topics: Abdominal Pain; Acute Disease; Endoscopy, Digestive System; Fundoplication; Gastric Dilatation; Huma | 2018 |
[High intestinal haemorrhage in patient with Schöelin-Henoch purpura].
Topics: Abdominal Pain; Adult; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopy, Gastrointestinal; He | 2008 |
Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Drug Administration Schedul | 2011 |
Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome.
Topics: Abdominal Pain; Anti-Ulcer Agents; Child; Combined Modality Therapy; Diarrhea; Duodenal Ulcer; Follo | 2011 |
Duodenal ulceration in a patient with celiac disease and plasminogen I deficiency: coincidence or cofactors?
Topics: Abdominal Pain; Biopsy, Needle; Blood Chemical Analysis; Celiac Disease; Child; Deficiency Diseases; | 2011 |
An unusual referral for epigastric pain, nausea, abdominal bloating, diarrhea, and weight loss.
Topics: Abdominal Pain; Adult; Anti-Ulcer Agents; Biopsy; Celiac Disease; Diarrhea; Diet, Gluten-Free; Duode | 2012 |
Giant gastric folds in a patient with hypoalbuminaemia.
Topics: Abdominal Pain; Aged; Anti-Inflammatory Agents; Edema; Endoscopy, Digestive System; Gastritis, Hyper | 2013 |
Nonhealing gastric ulcer caused by chronic alendronate administration.
Topics: Abdominal Pain; Aged; Alendronate; Anti-Ulcer Agents; Bone Resorption; Drug Administration Schedule; | 2002 |
[Pantoprazole-induced hepatitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdomen; Abdominal Pain; Anti-Ulcer Agents; Benzimidazoles; | 2003 |
[Pantoprazole-induced hepatitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Benzimidazoles; Chemical | 2003 |
Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis?
Topics: Abdominal Pain; Anti-Ulcer Agents; Dyspepsia; Gastritis; Gastroesophageal Reflux; Helicobacter Infec | 2004 |
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal U | 2004 |
The use of subcutaneous omeprazole in the treatment of dyspepsia in palliative care patients.
Topics: Abdominal Pain; Aged; Anti-Ulcer Agents; Dyspepsia; Enzyme Inhibitors; Female; Humans; Injections, S | 2004 |
Hyponatraemia, fever, vomiting, severe abdominal pain, and weight loss associated with omeprazole.
Topics: Abdominal Pain; Female; Fever; Humans; Hyponatremia; Middle Aged; Omeprazole; Proton Pump Inhibitors | 2005 |
Helicobacter pylori and recurrent pain abdomen.
Topics: Abdominal Pain; Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Endos | 2005 |
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ul | 2005 |
Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Anorexia; Anti-Ulcer Agents; Ch | 2006 |
Adverse events reporting.
Topics: Abdominal Pain; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Drug-Related Side Effects an | 2007 |
[Typhoid fever and acute pancreatitis: two cases].
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Ceftriaxone; Female; | 2007 |
Collagenous gastritis: a rare cause of abdominal pain and iron-deficiency anemia.
Topics: Abdominal Pain; Anemia, Iron-Deficiency; Anti-Ulcer Agents; Biopsy; Child; Collagen; Collagen Diseas | 2007 |
Esophageal candidiasis following omeprazole therapy: a report of two cases.
Topics: Abdominal Pain; Adolescent; Adult; Candidiasis; Esophageal Diseases; Female; Gastritis; Humans; Keto | 1995 |
Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy.
Topics: Abdominal Pain; Adolescent; Child; Chronic Disease; Drug Resistance; Esophagitis, Peptic; Gastritis; | 1995 |
Epigastric pain unrelieved by omeprazole.
Topics: Abdominal Pain; Adult; Anti-Ulcer Agents; Barrett Esophagus; Diagnosis, Differential; Gastroesophage | 1996 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-U | 1998 |
Rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adenosine Triphosphatases; Anti-Ulcer Agent | 1999 |
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Adverse Drug Reaction Reporting Syst | 2000 |
Helicobacter pylori infection in recurrent abdominal pain.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; C | 2000 |
[Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole].
Topics: Abdominal Pain; Anti-Ulcer Agents; Edema; Exudates and Transudates; Female; Gastritis; Humans; Lymph | 2000 |